Monocyte chemoattractant protein-1 but not tumor necrosis factor-α is correlated with monocyte infiltration in mouse lipid lesions

Circulation

Volumn 99, Issue 17, 1999, Pages 2310-2316

  Reckless, Jill ^a,c   Rubin, Edward M ^b   Verstuyft, Judy B ^b   Metcalfe, James C ^a   Grainger, David J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Aorta; Atherosclerosis; Lesion; Lipids; Monocytes

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; FEMALE; IMMUNOCYTOCHEMISTRY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032925610     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.17.2310     Document Type: Article

References (49)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Segrest JP, Anantharamaiah GM. Pathogenesis of atherosclerosis. Curr Opin Cardiol. 1994;9:404-410.
3. Falk E. Why do plaques rupture? Circulation. 1992;86:30-42.
4. Schwartz SM, Deblois D, Obrien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
5. Fuster V, Fallon JT, Badimon JJ, Nemerson Y. The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost. 1997;78:247-255.
6. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardialinfarction, sudden ischemic death, and crescendo angina. Br Heart J. 1985;53:363-373.
7. van der Wal AC, Koch KT, Piek JJ, deBoer OJ, Becker AE. Inflammation in atherosclerotic plaques: a clinically crucial event. Fibrinol Proteolysis. 1997:11(Suppl 1):125-128.
8. Davies MJ. Remodeling, response to injury, and repair in the arterial-wall. Curr Opin Cardiol. 1990;5:387-391.
9. Davies MJ. Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation. 1992;85:19-24.
10. Raines EW, Ross R. Multiple growth-factors are associated with lesions of atherosclerosis: specificity or redundancy. Bioessays. 1996;18: 271-282.
11. Rosenfeld ME, Pestel E. Cellularity of atherosclerotic lesions. Coron Artery Disease. 1994;5:189-197.
12. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504-512.
13. Duplaa C, Couffinhal T, Labat L, Moreau C, Petitjean ME, Doutre MS, Lamaziere JMD, Bonnet J. Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis. 1996;121:253-266.
14. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell. 1990;62:3-6.
15. Thorne SA, Abbot SE, Stevens CR, Winyard PG, Mills PG, Blake DR. Modified low density lipoprotein and cytokines mediate monocyte adhesion to smooth muscle cells. Atherosclerosis. 1996;127:167-176.
16. Moyer CF, Sajuthi D, Tulli H, Williams JK. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. Am J Pathol. 1991;138: 951-960.
17. Alon R, Springer TA, Rossiter H, Kupper TS. Rolling of T-cells on P and E selectins under physiological flow is mediated by distinct cell-surface ligands. Clin Res. 1994;42:A232-A232.
18. Fahey TJ, Tracey KJ, Tekampolson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B. Macrophage inflammatory protein-1 modulates macrophage function. J Immunol. 1992;148:2764-2769.
19. Rollins BJ, Stier P, Ernst T, Wong GG. The human homolog of the Je gene encodes a monocyte secretory protein. Mol Cell Biol. 1989;9: 4687-4695.
20. Uguccioni M, Dapuzzo M, Loetscher M, Dewald B, Baggiolini M. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1-alpha and MIP-1-beta on human monocytes. Eur J Immunol. 1995;25:64-68.
21. Rus HG, Niculescu F, Vlaicu R. Tumor-necrosis-factor-alpha in human arterial-wall with atherosclerosis. Atherosclerosis. 1991;89:247-254.
22. Endres M, Laufs U, Merz H, Kaps M. Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke. 1997;28: 77-82.
23. Lawn RM, Pearle AD, Kunz LL, Rubin EM, Reckless J, Metcalfe JC, Grainger DJ. Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice. J Biol Chem. 1996;271:31367-31371.
24. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
25. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS. Cellular pathology of progressive atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia. Arteriosclerosis. 1983;3:87-101.
26. Havel RJ, Yamada N, Shames DM. Watanabe heritable hyperlipidemic rabbit: animal model for familial hypercholesterolemia. Arteriosclerosis. 1989:9(suppl I):I-33-I-38. Abstract.
27. Wanibuchi H, Dingemans KP, Becker AE, Ueda M, Naruko T, Tanizawa S. Nakamura K. Is the Watanabe heritable hyperlipidemic rabbit a suitable experimental model for percutaneous transluminal coronary angioplasty in humans: a light microscopic, immunohistochemical and ultrastructural study. J Am Coll Cardiol. 1993;21:1490-1496.
28. Yamada N, Inoue I, Kawamura M, Harada K, Watanabe Y, Shimano H, Gotoda T, Shimada M, Kohzaki K, Tsukada T, Shiomi M, Watanabe Y, Yazaki Y. Apolipoprotein-E prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. J Clin invest. 1992;89: 706-711.
29. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein-E gene inactivated by gene targeting in embryonic stem-cells. Proc Natl Acad Sci U S A. 1992;89: 4471-4475.
30. Plump AS, Smith JD, Hayek T, Aaltosetala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient mice created by homologous recombination in es cells. Cell. 1992;71:343-353.
31. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature. 1992;360:670-672.
32. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth-factor-beta is inhibited in transgenic apolipoprotein(a) mice. Nature. 1994;370:460-462.
33. Ishida BY, Blanche PJ, Nichols AV, Yashar M, Paigen B. Effects of atherogenic diet consumption on lipoproteins in mouse strains C57b1/6 and C3h. J Lipid Res. 1991;32:559-568.
34. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987;68: 231-240.
35. Paigen B, Holmes PA, Mitchell D, Albee D. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57b1/6, Ba1b/C, and C3h. Atherosclerosis. 1987;64:215-221.
36. Rubin EM, Ishida BY, Clift SM, Krauss RM. Expression of human apolipoprotein-A-I in transgenic mice results in reduced plasma-levels of murine apolipoprotein-A-I and the appearance of 2 new high-density-lipoprotein size subclasses. Proc Natl Acad Sci U S A. 1991; 88:434-438.
37. Mosedale DE, Metcalfe JC, Grainger DJ. Optimization of immunofluorescence methods by quantitative image analysis. J Histochem Cytochem. 1996;44:1043-1050.
38. Grainger DJ, Witchell CM, Metcalfe JC. Tamoxifen elevates transforming growth-factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat Med. 1995;1:1067-1073.
39. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ. Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb. 1994;14:1480-1497.
40. Patel STR, Willerson JT, Yeh ETH. Inhibition of alpha(4) integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation. 1998;97:75-81.
41. Zhang Y, Ramos BF, Jakschik B, Baganoff MP, Deppeler CL, Meyer DM, Widomski DL, Fretland DJ, Bolanowski MA. Interleukin-8 and mast cell-generated tumor-necrosis-factor-alpha in neutrophil recruitment. Inflammation. 1995;19:119-132.
42. Weg VB, Walsh DT, Faccioli LH, Williams TJ, Feldmann M, Nourshargh S. LPS-induced In-111-eosinophil accumulation in guinea-pig skin: evidence for a role for TNF-alpha. Immunology. 1995;84:36-40.
43. Standiford TJ, Stricter RM, Lukacs NW, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage inflammatory protein-2 and tumor necrosis-factor. J lmmunol. 1995;155:2222-2229.
44. Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM. Atherogenesis in transgenic mice with human apolipoprotein-b and lipoprotein (a). J Clin Invest. 1995;96:1639-1646.
45. Lan HY, Paterson DJ, Atkins RC. Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int. 1991;40:425-433.
46. Zisman DA, Kunkel SL, Stricter RM, Tsai WC, Bucknell K, Wilkowski J. Standiford TJ. MCP-1 protects mice in lethal endotoxemia. J Clin Invest. 1997;99:2832-2836.
47. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (Mcaf/MCP-1). FASEB J. 1996;10:1418-1425.
48. Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D. Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Arteriosclerosis. 1990;10:316-323.
49. Vanotteren GM, Stricter RM, Kunkel SL, Paine R, Greenberger MJ, Danforth JM, Burdick MD, Standiford TJ. Compartmentalized expression of RANTES in a murine model of endotoxemia. J Immunol. 1995;154: 1900-1908.